Towards a consensus in rate versus rhythm control for management of atrial fibrillation: Insights from the PIAF trial

Cardiac Electrophysiology Review

Volumn 7, Issue 2, 2003, Pages 113-117

  Grönefeld, Gerian ^a   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anti arrhythmia agents; Atrial fibrillation; Cardioversion; Electric countershock; Randomized controlled trials; Rate control

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; WARFARIN;

ADULT; AGED; ARTIFICIAL HEART PACEMAKER; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART RHYTHM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PILOT STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; REVIEW; SIDE EFFECT; SINUS RHYTHM; SYMPTOM; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DISEASE MANAGEMENT; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; PILOT PROJECTS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS;

EID: 0346895286     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027469713179     Document Type: Review

References (19)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-226.
2. Nattel S. Therapeutic implications of atrial fibrillation mechanisms: Can mechanistic insights be used to improve AF management? Cardiovasc Res 2002;54:347-360.
3. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
4. Cheng CH, Sanders GD, Hlatky MA, Heidenreich P, McDonald KM, Lee BK, Larson MS, Owens DK. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 2000;133:864-876.
5. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PI4F): A randomised trial. Lancet 2000;356:1789-1794.
6. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
7. van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
8. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-1696.
9. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-1923.
10. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT Jr, Hawkinson RW, Pritchett EL. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J 1992;124:381-386.
11. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, Ding YA, Chang MS. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998;31:637-644.
12. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists. Circulation 1999;99:3028-3035.
13. Gronefeld GC, Lilienthal J, Kuck KH, Hohnloser SH. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: Results from a prospective randomized study. Eur Heart J 2003; 24:1430-1436.
14. The AFFIRM investigators. Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study. Am Heart J 2002;143:991-1001.
15. Epstein AE, Vidaillet H, Greene HL, Curtis AB, Ellenbogen KA, Simmons T, Mickel M. Frequency of symptomatic atrial fibrillation in patients enrolled in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. J Cardiovasc Electrophysiol 2002;13:667-671.
16. Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: Specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002;13:399-405.
17. The AF-CHF Trial Investigators. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002;144:597-607.
18. Singh BN. Current antiarrhythmic drugs: An overview of mechanisms of action and potential clinical utility. J Cardiovasc Electrophysiol 1999;10:283-301.
19. Connolly SJ. Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts. Am Heart J 2003;145:418-423.